Cargando…

Lifestyle and silymarin: a fight against liver damage in NAFLD associated - prediabetic disease

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is common in both prediabetic patients and healthy overweight individuals, yet it remains understudied. This study investigates the effects of hepatic steatosis on fibrosis and evaluates the major predictors of liver injury in prediabetes and whet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colletta, Cosimo, Colletta, Alessandro, Placentino, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843772/ https://www.ncbi.nlm.nih.gov/pubmed/33520810 http://dx.doi.org/10.1007/s40200-020-00576-3

Ejemplares similares

The progression of hepatorenal syndrome–acute kidney injury in acute alcohol-associated hepatitis: renal outcomes after liver transplant
por: Colletta, Alessandro, et al.
Publicado: (2023)

Kidney disease in patients with chronic liver disease: Does sex matter?
por: Cooper, Katherine M, et al.
Publicado: (2023)

The impact of COVID-19 on the duration of the liver transplant process in patients presenting for inpatient liver transplant evaluation
por: Cooper, Katherine, et al.
Publicado: (2022)

COVID-19 associated liver injury: A general review with special consideration of pregnancy and obstetric outcomes
por: Cooper, Katherine M., et al.
Publicado: (2022)

Prevalence of Prediabetes and Diabetes and Metabolic Profile of Patients With Nonalcoholic Fatty Liver Disease (NAFLD)
por: Ortiz-Lopez, Carolina, et al.
Publicado: (2012)

Multidisciplinary lifestyle intervention is associated with improvements in liver damage and in surrogate scores of NAFLD and liver fibrosis in morbidly obese patients
por: Bischoff, Monika, et al.
Publicado: (2022)

The Challenges of Providing Diabetes Education in Resource-Limited Settings to Women With Diabetes in Pregnancy: Perspectives of an Educator
por: Goldschmidt, Virginia J., et al.
Publicado: (2016)

Hepatoprotective activity of silymarin encapsulation against hepatic damage in albino rats
por: Mukhtar, Shanza, et al.
Publicado: (2021)

Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Carneros, David, et al.
Publicado: (2020)

Silymarin in Combination with Vitamin C, Vitamin E, Coenzyme Q10 and Selenomethionine to Improve Liver Enzymes and Blood Lipid Profile in NAFLD Patients
por: Curcio, Annalisa, et al.
Publicado: (2020)

Changes in expression of transforming growth factor beta mRNA isoforms in patients undergoing tamoxifen therapy.
por: Benson, J. R., et al.
Publicado: (1997)

How regional economic structure matters in the era of COVID-19: resilience capacity of U.S. states
por: Kim, Ayoung, et al.
Publicado: (2022)

Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
por: Federico, Alessandro, et al.
Publicado: (2017)

Severity of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus: Relationship between Nongenetic Factors and PNPLA3/HSD17B13 Polymorphisms
por: Bellan, Mattia, et al.
Publicado: (2019)

Protective Effects of Silymarin and Silibinin against DNA Damage in Human Blood Cells
por: Fernandes Veloso Borges, Flávio, et al.
Publicado: (2018)

Efficacy and Safety of Sofosbuvir and Ribavirin in an Italian Cohort of HCV Genotype 2 Elderly Cirrhotic Patients
por: Smirne, Carlo, et al.
Publicado: (2022)

Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)
por: Cuthbertson, Daniel J., et al.
Publicado: (2021)

Can we prevent breast cancer?
por: Baum, M., et al.
Publicado: (1991)

Effect of silymarin in diabetes mellitus patients with liver diseases
por: Jose, Manonmani Alvin, et al.
Publicado: (2011)

Long-Term Satisfaction and Patient-Centered Outcomes of Deep Brain Stimulation in Parkinson’s Disease
por: Karl, Jessica A., et al.
Publicado: (2018)

Prediabetes: lifestyle, pharmacotherapy or regulation?
por: Shaw, Jonathan E.
Publicado: (2019)

Role of UDP-Glucuronosyltransferase 1A1 in the Metabolism and Pharmacokinetics of Silymarin Flavonolignans in Patients with HCV and NAFLD
por: Xie, Ying, et al.
Publicado: (2017)

Efficient Eradication of Mature Pseudomonas aeruginosa Biofilm via Controlled Delivery of Nitric Oxide Combined with Antimicrobial Peptide and Antibiotics
por: Ren, Hang, et al.
Publicado: (2016)

Protective effects of silymarin against bisphenol A-induced hepatotoxicity in mouse liver
por: Zaulet, Mihaela, et al.
Publicado: (2017)

The Impact of NAFLD and Waist Circumference Changes on Diabetes Development in Prediabetes Subjects
por: Lee, Jiwoo, et al.
Publicado: (2019)

Silymarin: An option to treat non-alcoholic fatty liver disease
por: Colica, Carmela, et al.
Publicado: (2017)

Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
por: Gillessen, Anton, et al.
Publicado: (2020)

Chronic Liver Disease and Silymarin: A Biochemical and Clinical Review
por: Tighe, Sean P., et al.
Publicado: (2020)

Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD
por: Liang, Jun, et al.
Publicado: (2018)

Delayed referral for liver transplant evaluation worsens outcomes in chronic liver disease patients requiring inpatient transplant evaluation
por: Cooper, Katherine M, et al.
Publicado: (2023)

Gut Microbiota and Lifestyle Interventions in NAFLD
por: Houghton, David, et al.
Publicado: (2016)

S-Nitroso-N-acetylpenicillamine (SNAP) Impregnated Silicone Foley Catheters: A Potential Biomaterial/Device To Prevent Catheter-Associated Urinary Tract Infections
por: Colletta, Alessandro, et al.
Publicado: (2015)

Investigating the impact of silymarin on liver oxidative injury
por: Jamalian, Mohammad, et al.
Publicado: (2020)

Protective Effects of Silymarin Against D-Gal/LPS-Induced Organ Damage and Inflammation in Mice
por: Zhao, Xin, et al.
Publicado: (2021)

Antiviral activity of silymarin against chikungunya virus
por: Lani, Rafidah, et al.
Publicado: (2015)

Management of an iatrogenic duodenal perforation with a helical tack system in a patient with pancreatic cancer complicated by gastric outlet obstruction
por: Belkin, Dimitri, et al.
Publicado: (2023)

Silymarin protects liver against toxic effects of anti-tuberculosis drugs in experimental animals
por: Eminzade, Sude, et al.
Publicado: (2008)

Racial/ethnic and gender disparity in the severity of NAFLD among people with diabetes or prediabetes
por: Shaheen, Magda, et al.
Publicado: (2023)

The Effect of Mycotoxins and Silymarin on Liver Lipidome of Mice with Non-Alcoholic Fatty Liver Disease
por: Bechynska, Kamila, et al.
Publicado: (2021)

Free Radical-Scavenging, Anti-Inflammatory/Anti-Fibrotic and Hepatoprotective Actions of Taurine and Silymarin against CCl(4) Induced Rat Liver Damage
por: Abdel-Moneim, Ashraf M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ri7dlnptlv49rpe6dvnaohrjih